Author Question: A woman in labor at 34 weeks of gestation is hospitalized and treated with intravenous magnesium ... (Read 32 times)

viki · **on:** Jun 27, 2018

A woman in labor at 34 weeks of gestation is hospitalized and treated with intravenous magnesium sulfate for 18 to 20 hours.

When the magnesium sulfate is discontinued, which oral drug will probably be prescribed for at-home continuation of the tocolytic effect? a. Ritodrine
b. Terbutaline
c. Calcium gluconate
d. Magnesium sulfate

Question 2

How should the nurse respond when asked by the mother of a child with beta-thalassemia why the child is receiving deferoxamine?

a. To improve the anemia.
b. To decrease liver and spleen swelling.
c. To eliminate excessive iron being stored in the organs.
d. To prepare your child for a bone marrow transplant.

ttt030911 · **Reply #1 on:** Jun 27, 2018

Answer to Question 1

B
Feedback
A Ritodrine is the only drug approved by the FDA for tocolysis; however, it is
rarely used because of significant side effects.
B The woman receiving decreasing doses of magnesium sulfate is often switched
to oral terbutaline to maintain tocolysis.
C Calcium gluconate reverses magnesium sulfate toxicity. The drug should be
available for complications of magnesium sulfate therapy.
D Magnesium sulfate is usually given intravenously or intramuscularly. The patient
must be hospitalized for magnesium therapy because of the serious side effects
of this drug.

Answer to Question 2

C
Feedback
A Chronic transfusion therapy is the treatment for anemia. Deferoxamine is
administered to prevent complications from repeated transfusions.
B Deferoxamine is used to prevent organ damage, not as a treatment for existing
conditions such as hepatosplenomegaly.
C Multiple transfusions result in hemosiderosis. Deferoxamine is given to chelate
iron and prevent organ damage.
D Preparation for a bone marrow transplant does not include administration of
deferoxamine.